Simultaneous Determination of Multiple Drugs of Abuse and Relevant Metabolites in Urine by LC-MS-MS

A method was developed for the quantitative analysis of 30 drugs of abuse and their metabolites in urine, including opiates, barbiturates, amphetamines, cocaine, cannabinoids, phencyclidine, methadone, and benzodiazepines. This method uses solid-phase extraction (SPE) on an Oasis® HLB column followe...

Full description

Saved in:
Bibliographic Details
Published inJournal of analytical toxicology Vol. 31; no. 7; pp. 359 - 368
Main Authors Feng, June, Wang, Lanqing, Dai, Ingrid, Harmon, Tia, Bernert, John T.
Format Journal Article
LanguageEnglish
Published Niles, IL Oxford University Press 01.09.2007
Preston
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A method was developed for the quantitative analysis of 30 drugs of abuse and their metabolites in urine, including opiates, barbiturates, amphetamines, cocaine, cannabinoids, phencyclidine, methadone, and benzodiazepines. This method uses solid-phase extraction (SPE) on an Oasis® HLB column followed by liquid chromatography-tandem mass spectrometry. Analytes were quantified by multiple reaction monitoring with the deuterated analogues as internal standards, using an atmospheric pressure ionization-electrospray interface. The method was validated by examining specificity, precision, accuracy, linearity, recovery, reproducibility, and detection limits. The limits of detection ranged from 9 pg/mL to 2.29 ng/mL in urine depending on the analyte. The SPE procedure was automated on a RapidTrace® workstation to increase analytical throughput, and the results obtained via automated SPE were compared to those obtained by manual SPE to examine carryover effect, precision, accuracy, recovery, and reproducibility. To evaluate method performance, 108 urine samples were collected anonymously and tested for the presence of these drugs.
Bibliography:istex:351EDE284B5504CC37A6CE8717C7D6C99813948D
Use of trade names and commercial sources is for identification only and does not constitute endorsement by the U.S. Department of Health and Human Services or CDC. The Findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.
ark:/67375/HXZ-V24KKJL8-T
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0146-4760
1945-2403
DOI:10.1093/jat/31.7.359